[HTML][HTML] Pathological chemotherapy response score is prognostic in tubo-ovarian high-grade serous carcinoma: a systematic review and meta-analysis of individual …

PA Cohen, A Powell, S Böhm, CB Gilks… - Gynecologic …, 2019 - Elsevier
Objective There is a need to develop and validate biomarkers for treatment response and
survival in tubo-ovarian high-grade serous carcinoma (HGSC). The chemotherapy response …

Screening for ovarian cancer: a pilot randomised controlled trial

IJ Jacobs, SJ Skates, N MacDonald, U Menon… - The Lancet, 1999 - thelancet.com
Background The value of screening for ovarian cancer is uncertain. We did a pilot
randomised trial to assess multimodal screening with sequential CA 125 antigen and …

[PDF][PDF] Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and …

AG Rockall, SA Sohaib, MG Harisinghani… - Journal of clinical …, 2004 - researchgate.net
Purpose Lymph node metastases affect management and prognosis of patients with
gynecologic malignancies. Preoperative nodal assessment with computed tomography or …

[HTML][HTML] Cytoreductive surgery in ovarian cancer

C Pomel, A Jeyarajah, D Oram, J Shepherd… - Cancer …, 2007 - ncbi.nlm.nih.gov
As the overall prognosis for patients with ovarian cancer is poor, the management of this
condition should be restricted to expert multi-disciplinary teams in gynaecological oncology …

[PDF][PDF] Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer

U Menon, SJ Skates, S Lewis, AN Rosenthal… - J Clin …, 2005 - researchgate.net
Prospective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian Cancer
Page 1 Prospective Study Using the Risk of Ovarian Cancer Algorithm to Screen for Ovarian …

[PDF][PDF] Chemotherapy response score: development and validation of a system to quantify histopathologic response to neoadjuvant chemotherapy in tubo-ovarian high …

S Böhm, A Faruqi, I Said, M Lockley… - Journal of Clinical …, 2015 - researchgate.net
Chemotherapy Response Score: Development and Validation of a System to Quantify
Histopathologic Response to Neoadjuvant Chemothe Page 1 Chemotherapy Response Score …

Neoadjuvant chemotherapy modulates the immune microenvironment in metastases of tubo-ovarian high-grade serous carcinoma

S Böhm, A Montfort, OMT Pearce, J Topping… - Clinical Cancer …, 2016 - AACR
Purpose: The purpose of this study was to assess the effect of neoadjuvant chemotherapy
(NACT) on immune activation in stage IIIC/IV tubo-ovarian high-grade serous carcinoma …

Surgical treatment of stage IA2 cervical cancer

F Kokka, A Bryant, E Brockbank… - Cochrane Database of …, 2014 - cochranelibrary.com
Background Cervical cancer is the second most common cancer among women up to 65
years of age and is the most frequent cause of death from gynaecological cancers …

Role of MR imaging in the selection of patients with early cervical carcinoma for fertility-preserving surgery: initial experience

PD Peppercorn, AR Jeyarajah, R Woolas… - Radiology, 1999 - pubs.rsna.org
PURPOSE: To assess whether magnetic resonance (MR) imaging can be used for reliable
prediction of proximal extension of cervical carcinoma into the myometrium. MATERIALS …

[HTML][HTML] Implementation of multigene germline and parallel somatic genetic testing in epithelial ovarian cancer: SIGNPOST study

D Chandrasekaran, M Sobocan, O Blyuss, RE Miller… - Cancers, 2021 - mdpi.com
Simple Summary Multigene testing in ovarian cancer has received increased support due to
its 'applicability for cancer treatment and the impact it has on cancer prevention in families …